Medindia
Medindia LOGIN REGISTER
Advertisement

Medical and Recreational Use of Cannabis is Projected to Grow

Thursday, April 19, 2018 Drug News
Advertisement
FinancialBuzz.com News Commentary

NEW YORK, April 18, 2018 /PRNewswire/ --
Advertisement

According to a research by Oristep Consulting, the global medical cannabis market in 2016 was USD 12.67 billion and will reach USD 33.41 billion by 2022 at a CAGR of 17.53% during the forecasted period. Scientific studies of the chemicals called cannabinoids have led to two FDA-approved medications that contain the chemicals in a pill form. The two main cannabinoids from the cannabis plant are THC and CBD, which are used for medical purposes as treatments fort increasing appetite, reduce nausea, decreasing pain, inflammation (swelling and redness), and muscle control problems. The report also indicates that North America leads the market holding nearly half of the market share in 2016. SinglePoint, Inc. (OTC: SING), PotNetwork Holdings, Inc. (OTC: POTN), mCig, Inc. (OTC: MCIG), American Cannabis Company, Inc. (OTC: AMMJ), MPX Bioceutical Corporation (OTC: MPXEF)
Advertisement

In states like California for example, where new recreational cannabis laws went into effect on January 1st, 2018, analysts are projecting an increase in sales of Cannabis. The legalization of adult-use sales in California will lead to the creation of nearly 99,000 cannabis industry jobs in the state by 2021, about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced effects are considered. Troy Dayton, CEO of The Arcview Group explained, "The economic excitement around the legal cannabis industry is no longer just theory. Due to the giant impact adult-use legalization is already having in the United States, it's vital for key stakeholders to understand the full impact of legalization, beyond just retail sales numbers."

SinglePoint, Inc. (OTC: SING) earlier this morning the company announced breaking news that it has a, "Letter of Intent to wholly acquire Phoenician Engineering. Headquartered in Phoenix Arizona, Phoenician provides both consumer products as well as commercial grade equipment. Phoenicians' main products are medical grade grinders for consumers and soon to launch a grinder for commercial use. The company is currently in dispensaries throughout America and ships products internationally.

Phoenician currently has nine issued patents, three trademarks and additional patents pending. This will provide SinglePoint valuable IP to add to its growing asset class. Phoenician has also worked with multiple influencers such as Sublime with Rome and more. Phoenician is one of the most well-known consumers grinders in the market because of its quality and lifetime guarantee. The founders will stay on board through the acquisition and continue to grow the company with SinglePoint. SinglePoint plans to help increase, the already profitable sales, through ecommerce and online advertising.

SinglePoint and Phoenician are currently working through due diligence and the completed transaction is expected to happen soon. "We are ready to close this deal. We have 100% confidence in the founders of the company. They have built a sustainable, scalable business. We believe we can help take it to the next level. They are right in our backyard here in Phoenix so working closely alongside will be easy. With their product and an injection of our funding and ecommerce knowledge I believe we can 5x revenue in the first 18 months," states Greg Lambrecht CEO.   "We are incredibly exited to be working though due diligence with SinglePoint.  This is a great opportunity for synergistic and collaborative efforts to come together and add tremendous value," states Colton Dukat, CEO of Phoenician.

As of April 16th 2018 SinglePoint has concluded its two year audit and plans to file a form-10 to become fully reporting. Management believes this will give the company additional access to more capital on better funding terms. This capital will be used for acquisitions such as Phoenician Engineering and others in order to grow the company revenues and increase shareholder value. To see Phoenician Engineering Products please see https://phoenicianengineering.com/ ."

PotNetwork Holdings, Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. Recently, the company announced record breaking sales performance for March 2018. With over $2.2 million in sales revenue recorded across the month, the company has posted a 152% year over year increase when compared with March 2017. The company's wholly owned subsidiary, Diamond CBD, Inc. has been aggressively exploring new business development opportunities. As a provider of the highest quality CBD hemp oil products, Diamond CBD, Inc. continues to attract new customers in verticals such as petcare products which are allowing the brand to differentiate itself in the market.

mCig, Inc. (OTC: MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets. mCig, Inc. is committed to being the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. Recently, the company announces its third quarter and year to date results ending January 31, 2018.  MCIG recorded $780K in revenue bringing its year-to-date (YTD) total to $6.0 million in revenue, as compared to $2.2 million for the same period last year, an increase of 168%. During the quarter ending January 31, 2018, the Company expanded into agriculture with its expansion into the organic hemp growing business in New York and in its application process for cannabis growing and manufacturing licensure in California.  

American Cannabis Company, Inc. (OTCQB: AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. Earlier this year, the company announced that it has secured a consulting contract with Cloud 9 Apothecary in the state of California. In conjunction with the consulting agreement, ACC will acquire an equity stake in Cloud 9's project that is currently non-operational and in the development stage. This project, to be built-out and completed in Desert Springs, California, will comprise a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars. With the construction of this facility, Cloud 9 Apothecary's plans focus on wholesale cultivation and product manufacturing. Plans to shift into a fully integrated business model, complete with dispensing solutions, will be made in the near future as Cloud 9 plans to scale up operations organically.

MPX Bioceutical Corporation (OTCQB: MPXEF) provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to three medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. Recently, the company announced that it has signed a letter of intent to acquire 100% of the issued and outstanding shares of Canveda Inc.  a Licensed Producer under Health Canada's Access to Cannabis for Medical Purposes Regulations. Canveda is a private company operating in Peterborough, Ontario from a fully built-out facility that is ready to commence its first production run and is capable of producing approximately 1,000-1,200 kilograms of high quality cannabis flower annually.

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For singlepoint inc. financial news dissemination and PR services, FinancialBuzz.com expects to be compensated five thousand dollars for financial news dissemination and PR services by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .

Media Contact: [email protected] +1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close